The Board has determined that the veteran's peripheral neuropathy, including as due to Agent Orange exposure, was not incurred in or aggravated by service and may not be presumed to have been incurred as a result of such service.
The deciding factor: There is no evidence showing acute and subacute peripheral neuropathy within one year following the last date of herbicide exposure, nor any causal relationship between the veteran's exposure to Agent Orange in service and his diagnosed peripheral neuropathy.
- Claimed conditions
- bilateral neuropathy of the lower extremities
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- November 17, 2008
- Citation
- 0839378
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0839378.
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Dismissed
The veteran's appeal for service connection of bilateral neuropathy, chloracne/cutane tarda, and coronary artery disease was dismissed because the veteran requested to withdraw the appeal.
- Remanded (sent back)
The Board has remanded the Veteran's claims of service connection for diabetes type II and bilateral neuropathy of the lower extremities, as both conditions are related to his exposure to PFAS during active duty. The AOJ is instructed to obtain additional evidence confirming the Veteran's exposure to PFAS and to provide a VA examination to determine if his diabetes type II originated during or is etiologically related to service.
- Remanded (sent back)
The Board has remanded the claims for initial review by the AOJ of new evidence, including VA treatment records associated with the Veteran's claim folder since December 2020. The claims will be adjudicated in light of this additional evidence.
- Granted
The Veteran's diffuse large cell lymphoma, diabetes mellitus, type II, and bilateral lower extremity neuropathy are granted as service-connected due to herbicide exposure in Thailand. The balance disability is remanded for further development.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.